Hematologically important mutations: X-linked chronic granulomatous disease (third update)
Chronic granulomatous disease (CGD) is an immunodeficiency disorder affecting about 1 in 250,000 individuals. The disease is caused by a lack of superoxide production by the leukocyte enzyme NADPH oxidase. Superoxide is used to kill phagocytosed micro-organisms in neutrophils, eosinophils, monocytes...
Gespeichert in:
Veröffentlicht in: | Blood cells, molecules, & diseases molecules, & diseases, 2010-10, Vol.45 (3), p.246-265 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Chronic granulomatous disease (CGD) is an immunodeficiency disorder affecting about 1 in 250,000 individuals. The disease is caused by a lack of superoxide production by the leukocyte enzyme NADPH oxidase. Superoxide is used to kill phagocytosed micro-organisms in neutrophils, eosinophils, monocytes and macrophages. The leukocyte NADPH oxidase is composed of five subunits, of which the enzymatic component is gp91-
phox, also called Nox2. This protein is encoded by the
CYBB gene on the X chromosome. Mutations in this gene are found in about 70% of all CGD patients. This article lists all mutations identified in
CYBB in the X-linked form of CGD. Moreover, apparently benign polymorphisms in
CYBB are also given, which should facilitate the recognition of future disease-causing mutations. |
---|---|
ISSN: | 1079-9796 1096-0961 1096-0961 |
DOI: | 10.1016/j.bcmd.2010.07.012 |